NCT01360476View on ClinicalTrials.gov

Vitamin D Therapy to Reduce Cardiac Damage Among Vulnerable Hypertensive Patients

NACompletedINTERVENTIONAL
Enrollment

354

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

November 30, 2015

Study Completion Date

November 30, 2015

Conditions
HypertensionLeft Ventricular Hypertrophy
Interventions
DIETARY_SUPPLEMENT

cholecalciferol (Vitamin D)

50,000 UI, chewable wafer every 2 weeks for 52 weeks (27 total doses)

DIETARY_SUPPLEMENT

Placebo

chewable wafer every 2 weeks for 52 weeks (27 total doses)

Trial Locations (1)

48201

Detroit Receiving Hospital, Detroit

All Listed Sponsors
collaborator

National Institute on Minority Health and Health Disparities (NIMHD)

NIH

lead

Wayne State University

OTHER

NCT01360476 - Vitamin D Therapy to Reduce Cardiac Damage Among Vulnerable Hypertensive Patients | Biotech Hunter | Biotech Hunter